‌

US Patent 11884665 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Patent 11884665 was granted and assigned to Incyte on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Incyte

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118846650

Patent Inventor Names

Taisheng Huang0

Xiaozhao Wang0

Date of Patent

January 30, 2024

Patent Application Number

178411660

Date Filed

June 15, 2022

Patent Citations

‌

US Patent 7488802 Antibodies against PD-1

‌

US Patent 7501411 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

‌

US Patent 7511050 Purinone derivatives as HM74A agonists

‌

US Patent 7563788 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents

‌

US Patent 7635757 B7-4 Antibodies and uses therefor

‌

US Patent 7674791 Triazolopyrazines and methods of making and using the same

‌

US Patent 7700594 Fused bicyclic mTOR inhibitors

‌

US Patent 7709468 Imidazo based heterocycles

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11884665 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API